Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Constipation-predominant Irritable Bowel Syndrome

Trial Profile

Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Constipation-predominant Irritable Bowel Syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2016

At a glance

  • Drugs Linaclotide (Primary)
  • Indications Constipation; Irritable bowel syndrome
  • Focus Adverse reactions
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 19 May 2016 According to an Ironwood Pharmaceuticals media release, the company will present clinical data from this study at the Digestive Disease Week (DDW) 2016.
    • 25 Nov 2014 New source identified and integrated (ClinicalTrials.gov; NCT01714843).
    • 01 Dec 2013 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top